六黄清肺汤治疗风温肺热病（热毒蕴肺，气阴两伤）的临床观察

发布时间：2017-12-31 00:32

本文关键词：六黄清肺汤治疗风温肺热病（热毒蕴肺，气阴两伤）的临床观察　出处：《长春中医药大学》2016年硕士论文　论文类型：学位论文

【摘要】：目的:本课题研究内容属中医内科学呼吸系统领域,研究性质为临床疗效观察,目的是从脏腑相关、脏腑相干出发,探讨风温肺热病热毒为患,耗伤气阴,通过应用六黄清肺汤治疗风温肺热病(热毒蕴肺,气阴两伤)的临床疗效探索观察,验证风温肺热病(热毒蕴肺,气阴两伤)的中医中药系统治疗,探讨风温肺热病在发病机制及治疗方面的新途径。方法:从2014年12月-2014年12月长春中医药大学附属医院肺病科门诊及住院患者,取符合风温肺热病(热毒蕴肺,气阴两伤证)的患者共72例,随机分成2组。其中治疗组36例,予盐酸左氧氟沙星注射液静点及口服六黄清肺汤中药治疗,对照组36例,予盐酸左氧氟沙星注射液静点治疗。观察治疗组和对照组患者治疗前后退热时间,治愈时间,临床疗效对比。结果:治疗组共36例,其中治愈21例,显效10例,有效3例,无效2例,总有效率为94.44%;对照组共30例,其中治愈16例,显效5例,有效5例,无效4例,总有效率为86.67%,对照组脱落6例,治疗组总有效率高于对照组。经统计学检验处理分析后,两组资料对比治疗组疗效优于对照组(P0.05)。结论:风温肺热病西医参考对照社区获得性肺炎(CAP),社区获得性肺炎是临床常见病,且发病率高,结合目前我国抗菌药物应用现状,多数患者存在耐药菌的可能,抗菌药物应用级别越来越高,最终会导致高级耐药致病菌的产生,导师王檀教授总结多年临床经验得出风温肺热病是以热毒贯穿始终的,部分患者的发病机制,存在热毒蕴肺,气阴两伤,本临床观察有利于进一步完善风温肺热病的中医理论体系,以更好的指导临床实践,提高对该病的诊断及治疗,使患者最短时间恢复健康,回归社会,而且中药治疗安全可靠。
[Abstract]:Objective: the research content belongs to the Chinese medicine respiratory system, the nature of the clinical curative effect observation, the purpose is from the relevant organs, organs based on coherent, explore the wind warm lung heat toxin is suffering from fever, haoshangqiyin, through the application of six yellow Qingfei Decoction in the treatment of fever (wind warm lung heat in the lung, Qi and Yin two injuries the observation of clinical curative effect), validation of wind warm lung heat disease (heat toxin in the lung, Qi and Yin two injuries) Chinese medicine treatment system, explore the new way of wind warm lung heat disease in pathogenesis and treatment. Methods: patients from December 2014 -2014 pulmonary disease department of the Affiliated Hospital of Changchun University of Traditional Chinese Medicine in December of outpatient and inpatient, with air temperature lung fever (heat in the lung, Qi and Yin two injury syndrome) a total of 72 patients were randomly divided into 2 groups. The treatment group of 36 cases, intravenous and oral administration to Levofloxacine Hydrochloride Injection six yellow Qingfei Decoction of Chinese medicine treatment, the control group of 36 cases, treated with levofloxacin hydrochloride Pefloxacin injection intravenous therapy. Observation of treatment group and control group before and after treatment in patients with fever time, healing time, the clinical efficacy was compared. Results: the treatment group 36 cases, 21 cases were cured, 10 cases markedly effective, 3 cases effective, 2 cases ineffective, the total effective rate was 94.44%; the control group of 30 cases, including 16 cases were cured, 5 cases markedly effective, 5 cases effective, 4 cases ineffective, the total effective rate was 86.67%, the control group. In 6 cases, the total efficiency of the treatment group than the control group. After treatment by statistics analysis, two groups compared the curative effect in treatment group than (P0.05). Conclusion: the wind warm lung heat western medicine reference of community-acquired pneumonia (CAP), community-acquired pneumonia is a common clinical disease, and the incidence rate is high, combines with the current usage of antibacterial drugs, most patients with drug-resistant bacteria, antibiotics application level more and more high, will eventually lead to high drug resistant pathogens, guide Division Professor Wang Tan that wind warm lung fever is to heat throughout the summary of years of clinical experience, the pathogenesis of some patients, there is heat in the lung, Qi and Yin two injuries, this clinical observation is conducive to further improve the theoretical system of traditional Chinese medicine wind warm lung heat disease, in order to better guide clinical practice, improve diagnosis and treatment of the disease, so that patients in the shortest time to restore health, return to society, and traditional Chinese medicine treatment is safe and reliable.

【学位授予单位】：长春中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R256.1

【参考文献】